Tag: Pascal Soriot

AstraZeneca announces $400 mn investment in reforestation and biodiversity in support of climate action and human health

AstraZeneca has announced a $400 million investment in its global AZ Forest programme, raising its commitment to plant 200 million trees by 2030 and ensure their long-term survival. This includes new or expanded projects in Brazil, India, Vietnam, Ghana and Rwanda that will contribute to the Company’s climate action, restore nature, promote biodiversity and build…

AstraZeneca to acquire US-based Alexion for $39 billion

AstraZeneca and Alexion Pharmaceuticals, Inc. (Alexion) have entered into a definitive agreement for AstraZeneca to acquire Alexion. The boards of directors of both companies have unanimously approved the acquisition. Subject to receipt of regulatory clearances and approval by shareholders of both companies, the acquisition is expected to close in Q3 2021, and upon completion, Alexion…

AstraZeneca to reduce global head count by over 5000 between 2013 – 2016

    AstraZeneca has come out with its list of strategic priorities while the company plans a return to growth and achieve scientific leadership. The actionables  being announced during the investors day briefing , introduces a series of measures that would lead to efforts and resources getting rightfully directed towards the businesses priority growth platforms…